Vascular dementia is among the most common etiologies of neurocognitive dysfunction. It is primarily caused by reduced blood flow to the brain, leading to memory loss, language difficulties, and executive function deficits. The pathophysiology involves neuronal damage, synaptic dysfunction, and neuroinflammation, leading to a progressive decline in neurocognitive abilities.

Stem cell therapy has the potential to neovascularise, stimulate neurogenesis, and restore damaged neuronal networks by secreting neurotrophic factors and modulating neuroinflammation. This cutting-edge approach consequently enhances cognitive function and improves the quality of life for patients with vascular dementia.

The Regentime procedure for Vascular dementia requires a stay of 5 days in Lebanon, with prices ranging from 22,500 USD to 32,000 USD.